172 related articles for article (PubMed ID: 29667113)
1. Lack of association between obesity and aggressiveness of differentiated thyroid cancer.
Grani G; Lamartina L; Montesano T; Ronga G; Maggisano V; Falcone R; Ramundo V; Giacomelli L; Durante C; Russo D; Maranghi M
J Endocrinol Invest; 2019 Jan; 42(1):85-90. PubMed ID: 29667113
[TBL] [Abstract][Full Text] [Related]
2. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Lack of association between obesity and aggressiveness of differentiated thyroid cancer.
Campennì A; Trimarchi F; Baldari S
J Endocrinol Invest; 2019 Jan; 42(1):107-108. PubMed ID: 30343357
[No Abstract] [Full Text] [Related]
4. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
Li CL; Dionigi G; Zhao YS; Liang N; Sun H
J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
[TBL] [Abstract][Full Text] [Related]
5. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.
Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676
[TBL] [Abstract][Full Text] [Related]
6. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
[TBL] [Abstract][Full Text] [Related]
7. [Association between body mass index and aggressiveness of papillary thyroid carcinoma].
Faure EN; Soutelo MJ; Fritz MC; Martín A; Musri Y; Lutfi R
Medicina (B Aires); 2018; 78(3):145-150. PubMed ID: 29940539
[TBL] [Abstract][Full Text] [Related]
8. Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study.
Dong Z; Liu W; Su F; Cheng R
Endocr Pract; 2023 Feb; 29(2):83-88. PubMed ID: 36481471
[TBL] [Abstract][Full Text] [Related]
9. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study.
Paes JE; Hua K; Nagy R; Kloos RT; Jarjoura D; Ringel MD
J Clin Endocrinol Metab; 2010 Sep; 95(9):4244-50. PubMed ID: 20519347
[TBL] [Abstract][Full Text] [Related]
10. Obesity and risk of differentiated thyroid cancer: A large-scale case-control study.
He Q; Sun H; Li F; Liang N
Clin Endocrinol (Oxf); 2019 Dec; 91(6):869-878. PubMed ID: 31479527
[TBL] [Abstract][Full Text] [Related]
11. Effects of concomitant obesity and diabetes on the aggressiveness and outcomes of differentiated thyroid cancer patients.
Elbasan O; Yavuz DG
Arch Endocrinol Metab; 2021 Nov; 65(4):455-461. PubMed ID: 33909380
[TBL] [Abstract][Full Text] [Related]
12. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
13. A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study.
Grani G; Gentili M; Siciliano F; Albano D; Zilioli V; Morelli S; Puxeddu E; Zatelli MC; Gagliardi I; Piovesan A; Nervo A; Crocetti U; Massa M; Samà MT; Mele C; Deandrea M; Fugazzola L; Puligheddu B; Antonelli A; Rossetto R; D'Amore A; Ceresini G; Castello R; Solaroli E; Centanni M; Monti S; Magri F; Bruno R; Sparano C; Pezzullo L; Crescenzi A; Mian C; Tumino D; Repaci A; Castagna MG; Triggiani V; Porcelli T; Meringolo D; Locati L; Spiazzi G; Di Dalmazi G; Anagnostopoulos A; Leonardi S; Filetti S; Durante C
J Clin Endocrinol Metab; 2023 Jul; 108(8):1921-1928. PubMed ID: 36795619
[TBL] [Abstract][Full Text] [Related]
14. Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study.
Chung YS; Lee JH; Lee YD
Surg Today; 2017 Apr; 47(4):506-512. PubMed ID: 27654453
[TBL] [Abstract][Full Text] [Related]
15. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
Lee SG; Lee WK; Lee HS; Moon J; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS; Lee J
Thyroid; 2017 Feb; 27(2):174-181. PubMed ID: 27750028
[TBL] [Abstract][Full Text] [Related]
16. Relationship between obesity, diabetes and the risk of thyroid cancer.
Oberman B; Khaku A; Camacho F; Goldenberg D
Am J Otolaryngol; 2015; 36(4):535-41. PubMed ID: 25794786
[TBL] [Abstract][Full Text] [Related]
17. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
Robenshtok E; Nachalon Y; Benbassat C; Hirsch D; Shimon I; Grossman A; Diker-Cohen T; Akirov A; Popovtzer A
Thyroid; 2017 Sep; 27(9):1171-1176. PubMed ID: 28791923
[TBL] [Abstract][Full Text] [Related]
18. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
19. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies.
Zhao ZG; Guo XG; Ba CX; Wang W; Yang YY; Wang J; Cao HY
J Int Med Res; 2012; 40(6):2041-50. PubMed ID: 23321160
[TBL] [Abstract][Full Text] [Related]
20. Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis.
Borowczyk M; Janicki A; Dworacki G; Szczepanek-Parulska E; Danieluk M; Barnett J; Antonik M; Kałużna M; Bromińska B; Czepczyński R; Bączyk M; Ziemnicka K; Ruchała M
J Endocrinol Invest; 2019 Jan; 42(1):45-52. PubMed ID: 29619749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
